Tyr147

Site Information
VyDEDSPyQNIkILH SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 450565

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 )
Disease tissue studied:	leukemia ( 1 ) , chronic myelogenous leukemia ( 1 ) , lymphoma ( 3 ) , anaplastic large cell lymphoma ( 3 )
Relevant cell line - cell type - tissue:	K562 (erythroid) ( 1 ) , SU-DHL1 (T lymphocyte) ( 2 , 3 )

References
1	Moritz A (2006) CST Curation Set: 1751; Year: 2006; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info
2	Rush J, et al. (2005) Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 23, 94-101 15592455 Curated Info
3	Moritz A (2003) CST Curation Set: 164; Year: 2003; Biosample/Treatment: cell line, SU-DHL1/-; Disease: anaplastic large cell lymphoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info